Format

Send to

Choose Destination
Curr Pharm Des. 2004;10(30):3725-39.

Targeting the assembly of the human immunodeficiency virus type I.

Author information

1
Unité INSERM 412, LaboRétro, Ecole Normale Supérieure de Lyon, IFR 128 Biosciences Lyon-Gerland, France. acimarel@ens-lyon.fr

Abstract

In the rush to develop anti-viral drugs against the human immunodeficiency virus type I (HIV-1), all the steps of the viral life cycle are potential targets of therapeutic intervention. In this review, we will explore the recent advances on strategies that aim at obstructing the formation, the release and the infectivity of newly formed virion particles from HIV-1 infected cells.

PMID:
15579067
DOI:
10.2174/1381612043382701
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center